BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19609052)

  • 1. Surface ECG characteristics of ventricular tachyarrhythmias before degeneration into ventricular fibrillation in patients with Brugada-type ECG.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Ohta M; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2009 Jul; 50(4):477-87. PubMed ID: 19609052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
    Eckardt L; Bruns HJ; Paul M; Kirchhof P; Schulze-Bahr E; Wichter T; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):742-9. PubMed ID: 12212690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach for the comparison of conduction abnormality between arrhythmogenic right ventricular cardiomyopathy/dysplasia and Brugada syndrome.
    Yodogawa K; Morita N; Kobayashi Y; Takayama H; Ohara T; Seino Y; Katoh T; Mizuno K
    Ann Noninvasive Electrocardiol; 2011 Jul; 16(3):263-9. PubMed ID: 21762254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocardial electrograms from the right ventricular outflow tract after induced ventricular fibrillation in patients with Brugada syndrome.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kofune T; Shindo A; Sugimura H; Nakai T; Kunimoto S; Kasamaki Y; Saito S; Hirayama A
    Circ J; 2007 Aug; 71(8):1258-62. PubMed ID: 17652891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.
    Nademanee K; Veerakul G; Chandanamattha P; Chaothawee L; Ariyachaipanich A; Jirasirirojanakorn K; Likittanasombat K; Bhuripanyo K; Ngarmukos T
    Circulation; 2011 Mar; 123(12):1270-9. PubMed ID: 21403098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle.
    Yamauchi Y; Aonuma K; Takahashi A; Sekiguchi Y; Hachiya H; Yokoyama Y; Kumagai K; Nogami A; Iesaka Y; Isobe M
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1041-8. PubMed ID: 16191113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram.
    Makimoto H; Kamakura S; Aihara N; Noda T; Nakajima I; Yokoyama T; Doi A; Kawata H; Yamada Y; Okamura H; Satomi K; Aiba T; Shimizu W
    Heart Rhythm; 2012 Feb; 9(2):242-8. PubMed ID: 21939629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patients.
    Hiratsuka A; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Yoshida M; Fukuda M; Matsuzaki M
    Circ J; 2012; 76(3):624-33. PubMed ID: 22251750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation.
    Hayashi M; Takatsuki S; Maison-Blanche P; Messali A; Haggui A; Milliez P; Leenhardt A; Extramiana F
    J Am Coll Cardiol; 2008 Mar; 51(12):1162-8. PubMed ID: 18355653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific arrhythmogenesis in patients with Brugada syndrome.
    Morita H; Fukushima-Kusano K; Nagase S; Takenaka-Morita S; Nishii N; Kakishita M; Nakamura K; Emori T; Matsubara H; Ohe T
    J Cardiovasc Electrophysiol; 2003 Apr; 14(4):373-9. PubMed ID: 12741708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic determinants of the polymorphic QRS morphology in idiopathic right ventricular outflow tract tachycardia.
    Igarashi M; Tada H; Kurosaki K; Yamasaki H; Akiyama D; Sekiguchi Y; Kuroki K; Machino T; Murakoshi N; Nakata Y; Kuga K; Nogami A; Aonuma K
    J Cardiovasc Electrophysiol; 2012 May; 23(5):521-6. PubMed ID: 22136173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome.
    Take Y; Morita H; Wu J; Nagase S; Morita S; Toh N; Nishii N; Nakamura K; Kusano KF; Ohe T; Ito H; Zipes DP
    Heart Rhythm; 2011 Jul; 8(7):1014-21. PubMed ID: 21315838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarifying the arrhythmogenic substrate for Brugada syndrome.
    Kofune M; Watanabe I; Ohkubo K; Ashino S; Okumura Y; Nagashima K; Mano H; Nakai T; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(5):290-4. PubMed ID: 22008438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kawauchi K; Yamada T; Kofune T; Hashimoto K; Shindo A; Sugimura H; Nakai T; Saito S; Hirayama A
    Circ J; 2007 Sep; 71(9):1437-41. PubMed ID: 17721024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.